MAGI2 is an independent predictor of biochemical recurrence in prostate cancer

ConclusionsThese results reveal that MAGI2 expression is reduced during prostate cancer progression and that retention of MAGI2 signal reduces odds of BCR. The study results further suggest a possible role of MAGI2 in prostate neoplasia. Decreased MAGI2 expression may help predict prostate cancer aggressiveness and provide new insight for treatment decisions and post‐operative surveillance intervals.

Source: The Prostate - March 14, 2018 Category: Urology & Nephrology Authors: Stephanie N. David, Shanna A. Arnold Egloff, Rajen Goyal, Peter E. Clark, Sharon Phillips, Lan L. Gellert, Omar Hameed, Giovanna A. Giannico Tags: ORIGINAL ARTICLE Source Type: research